Evidence of linkage and association on chromosome 20 for late-onset Alzheimer disease

Corder EH, Saunders AM, Strittmatter WJ, et al (1993) Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer’s disease in late onset families. Science 261:921–923 Saunders AM, Strittmatter WJ, Schmechel D, et al (1993) Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer’s disease. Neurology 43:1467–1472 Pericak-Vance MA, Grubber J, Bailey LR, et al (2000) Identification of novel genes in late-onset Alzheimer’s disease. Exp Gerontol 35:1343–1352 Bertram L, Blacker D, Mullin K, et al (2000) Evidence for genetic linkage of Alzheimer’s disease to chromosome 10q. Science 290:2302–2303 Ertekin-Taner N, Graff-Radford N, Younkin LH, et al (2000) Linkage of plasma Abeta42 to a quantitative locus on chromosome 10 in late-onset Alzheimer’s disease pedigrees. Science 290:2303–2304 Myers A, Holmans P, Marshall H, et al (2000) Susceptibility locus for Alzheimer’s disease on chromosome 10. Science 290:2304–2305 Pericak-Vance MA, Bass MP, Yamaoka LH, et al (1997) Complete genomic screen in late-onset familial Alzheimer disease. Evidence for a new locus on chromosome 12. JAMA 278:1237–1241 Kehoe P, Wavrant-De Vrieze F, Crook R, et al (1999) A full genome scan for late onset Alzheimer’s disease. Hum Mol Genet 8:237–245 Wu WS, Holmans P, Wavrant-DeVrieze F, et al (1998) Genetic studies on chromosome 12 in late-onset Alzheimer disease. JAMA 280:619–622 Rogaeva E, Premkumar S, Song Y, et al (1998) Evidence for an Alzheimer disease susceptibility locus on chromosome 12 and for further locus heterogeneity. JAMA 280:614–618 Olson JM, Goddard KA, Dudek DM (2001) The amyloid precursor protein locus and very-late-onset Alzheimer disease. Am J Hum Genet 69:895–899 Williams J, Holmans P, Turic D, et al (2002) Full genome screen for Alzheimer disease: stage III analysis. Am J Hum Genet 71:194 Olson JM, Goddard KA, Dudek DM (2002) A second locus for very-late-onset Alzheimer disease: a genome scan reveals linkage to 20p and epistasis between 20p and the amyloid precursor protein region. Am J Hum Genet 71:154–161 Blacker D, Haines JL, Rodes L, et al (1997) ApoE-4 and age at onset of Alzheimer’s disease: the NIMH genetics initiative. Neurology 48:139–147 Goddard KA, Witte JS, Suarez BK, Catalona WJ, Olson JM (2001) Model-free linkage analysis with covariates confirms linkage of prostate cancer to chromosomes 1 and 4. Am J Hum Genet 68:1197–1206 Goate A, Chartier-Harlin MC, Mullan M, et al (1991) Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer’s disease. Nature 349:704–706 Tanzi RE, Vaula G, Romano DM, et al (1992) Assessment of amyloid beta-protein precursor gene mutations in a large set of familial and sporadic Alzheimer disease cases. Am J Hum Genet 51:273–282 Abrahamson M, Grubb A, Olafsson I, Lundwall A (1987) Molecular cloning and sequence analysis of cDNA coding for the precursor of the human cysteine proteinase inhibitor cystatin C. FEBS Lett 216:229–233 Levy E, Carman MD, Fernandez-Madrid IJ, et al (1990) Mutation of the Alzheimer’s disease amyloid gene in hereditary cerebral hemorrhage, Dutch type. Science 248:1124–1126 Levy E, Sastre M, Kumar A, et al (2001) Codeposition of cystatin C with amyloid-beta protein in the brain of Alzheimer disease patients. J Neuropathol Exp Neurol 60:94–104 Deng A, Irizarry MC, Nitsch RM, Growdon JH, Rebeck GW (2001) Elevation of cystatin C in susceptible neurons in Alzheimer’s disease. Am J Pathol 159:1061–1068 Finckh U, KH von der, Velden J, et al (2000) Genetic association of a cystatin C gene polymorphism with late-onset Alzheimer disease. Arch Neurol 57:1579–1583 Crawford FC, Freeman MJ, Schinka JA, et al (2000) A polymorphism in the cystatin C gene is a novel risk factor for late-onset Alzheimer’s disease. Neurology 55:763–768 Parfitt M, Crook R, Roques P, Rossor M, Chartier-Harlin MC (1993) The Cystatin-C gene is not linked to early onset familial Alzheimer’s disease. Neurosci Lett 154:81–83 Dodel RC, Du Y, Depboylu C, et al (2002) A polymorphism in the cystatin C promoter region is not associated with an increased risk of AD. Neurology 58:664 Roks G, Cruts M, Slooter AJ, et al (2001) The cystatin C polymorphism is not associated with early onset Alzheimer’s disease. Neurology 57:366–367 Maruyama H, Izumi Y, Oda M, et al (2001) Lack of an association between cystatin C gene polymorphisms in Japanese patients with Alzheimer’s disease. Neurology 57:337–339 Beyer K, Lao JI, Gomez M, et al (2001) Alzheimer’s disease and the cystatin C gene polymorphism: an association study. Neurosci Lett 315:17–20 Howieson DB, Holm LA, Kaye JA, Oken BS, Howieson J (1993) Neurologic function in the optimally healthy oldest old. Neuropsychological evaluation. Neurology 43:1882–1886 Kaye JA, Swihart T, Howieson D, et al (1997) Volume loss of the hippocampus and temporal lobe in healthy elderly persons destined to develop dementia. Neurology 48:1297–1304 McNeal M, Zareparsi S, Dame A, et al (2001) Predictors of healthy brain aging. J Gerontol 56A:B294–B301 McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984) Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s Disease. Neurology 34:939–944 Kaye JA, Oken BS, Howieson DB, Howieson J, Holm LA, Dennison K (1994) Neurologic evaluation of the optimally healthy oldest old. Arch Neurol 51:1205–1211 Zhang L, Cui X, Schmitt K, Hubert R, Navidi W, Arnheim N (1992) Whole genome amplification from a single cell: implications for genetic analysis. Proc Natl Acad Sci U S A 89:5847–5851 Kuivaniemi H, Yoon S, Shibamura H, Skunca M, Vongpunsawad S, Tromp G (2002) Primer-extension preamplified DNA is a reliable template for genotyping. Clin Chem 48:1601–1604 Kruglyak L, Daly MJ, Reeve-Daly MP, Lander ES (1996) Parametric and nonparametric linkage analysis: a unified multipoint approach. Am J Hum Genet 58:1347–1363 Sham PC, Curtis D (1995) Monte Carlo tests for associations between disease and alleles at highly polymorphic loci. Ann Hum Genet 59:97–105 Goddard KA, Yu CE, Oshima J, et al (1996) Toward localization of the Werner syndrome gene by linkage disequilibrium and ancestral haplotyping: lessons learned from analysis of 35 chromosome 8p11.1–21.1 markers. Am J Hum Genet 58:1286–1302 Slatkin M, Excoffier L (1996) Testing for linkage disequilibrium in genotypic data using the Expectation-Maximization algorithm. Heredity 76:377–383 Rohrer L, Raulf F, Bruns C, Buettner R, Hofstaedter F, Schule R (1993) Cloning and characterization of a fourth human somatostatin receptor. Proc Natl Acad Sci USA 90:4196–4200 Strittmatter M, Cramer H, Reuner C, Strubel D, Hamann G, Schimrigk K (1997) Molecular forms of somatostatin-like immunoreactivity in the cerebrospinal fluid of patients with senile dementia of the Alzheimer type. Biol Psychiatry 41:1124–1130 Reinikainen KJ, Soininen H, Riekkinen PJ (1990) Neurotransmitter changes in Alzheimer’s disease: implications to diagnostics and therapy. J Neurosci Res 27:576–586 Molins A, Catalan R, Sahuquillo J, Castellanos JM, Codina A, Galard R (1991) Somatostatin cerebrospinal fluid levels in dementia. J Neurol 238:168–170 Yasuda M, Maeda K, Kakigi T, Minamitani N, Kawaguchi T, Tanaka C (1995) Low cerebrospinal fluid concentrations of peptide histidine valine and somatostatin-28 in Alzheimer’s disease: altered processing of prepro-vasoactive intestinal peptide and prepro-somatostatin. Neuropeptides 29:325–330 Lee DS, Tomita S, Kirino Y, Suzuki T (2000) Regulation of X11L-dependent amyloid precursor protein metabolism by XB51, a novel X11L-binding protein. J Biol Chem 275:23134–23138 Tabor HK, Risch NJ, Myers RM (2002) Opinion: candidate-gene approaches for studying complex genetic traits: practical considerations. Nat Rev Genet 3:391–397 Broman KW, Murray JC, Sheffield VC, White RL, Weber JL (1998) Comprehensive human genetic maps: individual and sex-specific variation in recombination. Am J Hum Genet 63:861–869